Robinhood Chain Token Ring Allegedly Extracts $18.4 Million Across 53 Launches 
Senate Sets December 8 Vote on Trump’s NASA Nominee Jared Isaacman 
UK Housebuilder Stocks Surge on New First-Time Buyer Loan Scheme 
RBA Set for September Rate Hike as Inflation Stays High 
Gold Slides Below $4,300 as Oil Surge Fuels Fed Rate Hike Bets 
Hengrui Shares Rise on $2.6 Billion Novo Nordisk Obesity Drug Deal 
Nissan Targets US Hybrid Growth With Rogue e-Power Launch 
Cogent Biosciences Soars 120% on Breakthrough Phase 3 Results for Bezuclastinib in GIST Treatment 
BlackRock’s Rick Rieder Favors Bonds Over Stocks as Treasury Yields Surge 
Asian Stocks Fall as Oil Surge, Bond Yields and AI Concerns Hit Markets 
CSL Partners With AWS to Bring AI Into Drug Research 
Eli Lilly’s Inluriyo Gains FDA Approval for Advanced Breast Cancer Treatment 
Stellar Hits Record 217 TPS as Institutional RWA Activity Surges 
HUTCHMED, AstraZeneca Seek FDA Approval for Lung Cancer Combo 
Asian Stocks Fall as Bond Yields and Oil Prices Surge 
FDA Adds Fatal Risk Warning to J&J and Legend Biotech’s Carvykti Cancer Therapy 
Add as a preferred source on Google
South Korean scientists have developed an artificial intelligence (AI)-based peptide detection model that can predict the antibiotic functionality of peptides antibiotic for hay bacillus, colon bacillus, staphylococcus aureus, and staph.
The research team from the National Institute of Biological Resources and Dongguk University applied the AI model that learned antibiotic peptide data for the transcriptome of the wolf spider’s venom gland and succeeded in exploring two types of new antibiotic peptides.
The spider venom’s peptide has the property of destroying cells and paralyzing nerves, and can thereby be used as a functional material in various areas, including medicines, food, and cosmetics.
